Umbilical Stem Cell Therapy Alleviates PAH Symptoms in Rats

Umbilical Stem Cell Therapy Alleviates PAH Symptoms in Rats

285430

Umbilical Stem Cell Therapy Alleviates PAH Symptoms in Rats

Mesenchymal stem cells (MSCs) derived from umbilical cord blood (UBC) showed more therapeutic benefits than those derived from adipose (fatty) tissue or bone marrow in a rat model of pulmonary arterial hypertension (PAH), a study reports. Specifically, into-the-vein (intravenous, IV) injections of UCB-MSCs reduced right ventricle dysfunction, vascular (blood vessel) alterations, and inflammation, and modulated PAH-regulating pathways. The study, “Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary…

You must be logged in to read/download the full post.